Alterity Therapeutics Limited (NASDAQ:ATHE) Shares Purchased by HB Wealth Management LLC

HB Wealth Management LLC grew its stake in shares of Alterity Therapeutics Limited (NASDAQ:ATHE) by 34.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 31,883 shares of the company’s stock after acquiring an additional 8,100 shares during the period. HB Wealth Management LLC owned about 0.44% of Alterity Therapeutics worth $110,000 at the end of the most recent reporting period.

Analyst Upgrades and Downgrades

Separately, Maxim Group initiated coverage on Alterity Therapeutics in a research report on Thursday, December 12th. They set a “buy” rating and a $8.00 price objective for the company.

Alterity Therapeutics Price Performance

Shares of NASDAQ:ATHE opened at $2.94 on Friday. The firm has a fifty day moving average of $2.51 and a two-hundred day moving average of $1.77. Alterity Therapeutics Limited has a 12-month low of $1.00 and a 12-month high of $4.71.

Alterity Therapeutics Company Profile

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia. The company’s lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson’s disease.